Position in VYGR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,068,705
-$213,376 QoQ
Shares Held
276,867
-15.1% QoQ
Ownership
0.458%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,063,537 across 407 Biotechnology names. VYGR ranks #172 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in VYGR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,068,705 | 276,867 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,282,081 | 326,230 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,015,307 | 217,411 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $685,104 | 220,291 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $789,543 | 233,593 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,370,063 | 241,634 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,532,312 | 261,934 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $2,178,752 | 275,443 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $2,948,057 | 316,655 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $2,730,574 | 323,528 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $2,441,180 | 314,991 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,065,698 | 355,083 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,773,602 | 359,741 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $1,962,948 | 321,795 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,905,025 | 321,795 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,681,737 | 284,558 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,668,652 | 350,217 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,394,738 | 514,664 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,061,926 | 784,003 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,798,880 | 919,826 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $6,351,696 | 1,348,556 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,374,998 | 611,888 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $3,767,084 | 353,054 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $4,021,526 | 318,663 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $2,666,098 | 291,377 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||